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Abstract
Background: Mangotoxin is an antimetabolite toxin that is produced by strains of Pseudomonas syringae pv.
syringae; mangotoxin-producing strains are primarily isolated from mango tissues with symptoms of bacterial apical
necrosis. The toxin is an oligopeptide that inhibits ornithine N-acetyl transferase (OAT), a key enzyme in the
biosynthetic pathway of the essential amino acids ornithine and arginine. The involvement of a putative
nonribosomal peptide synthetase gene (mgoA) in mangotoxin production and virulence has been reported.
Results: In the present study, we performed a RT-PCR analysis, insertional inactivation mutagenesis, a promoter
expression analysis and terminator localisation to study the gene cluster containing the mgoA gene. Additionally, we
evaluated the importance of mgoC, mgoA and mgoD in mangotoxin production. A sequence analysis revealed an
operon-like organisation. A promoter sequence was located upstream of the mgoB gene and was found to drive lacZ
transcription. Two terminators were located downstream of the mgoD gene. RT-PCR experiments indicated that the
four genes (mgoBCAD) constitute a transcriptional unit. This operon is similar in genetic organisation to those in the
three other P. syringae pathovars for which complete genomes are available (P. syringae pv. syringae B728a, P. syringae
pv. tomato DC3000 and P. syringae pv. phaseolicola 1448A). Interestingly, none of these three reference strains is capable
of producing mangotoxin. Additionally, extract complementation resulted in a recovery of mangotoxin production
when the defective mutant was complemented with wild-type extracts.
Conclusions: The results of this study confirm that mgoB, mgoC, mgoA and mgoD function as a transcriptional
unit and operon. While this operon is composed of four genes, only the last three are directly involved in
mangotoxin production.
Background
Antimetabolite toxins are generally small metabolites
that exhibit strong effects in plant cells by causing an
increase in disease symptoms [1]. Various toxic sub-
stances produced by pathovars of Pseudomonas syringae
have been well characterised. Each antimetabolite toxin
inhibits a specific step in the glutamine and arginine
biosynthesis pathways of the host, enhancing disease
symptoms and increasing the virulence of the bacterial
pathogen. The most well-studied antimetabolite toxins
are tabtoxin and phaseolotoxin [2].
Tabtoxin is a monocyclic b-lactam that specifically inhi-
bits the enzyme glutamine synthetase (GS, EC 6.3.1.2).
This toxin is produced by P. syringae pv. tabaci, pv. coro-
nafaciens and pv. garcae [3]. The biosynthetic pathway of
tabtoxin is not well understood, and tabtoxin biosynthesis
may diverge from the lysine biosynthetic pathway prior to
the formation of diaminopimelate [4,5]. A genetic analysis
of tabtoxin production revealed the presence of biosyn-
thetic genes at the att site adjacent to the lysC tRNA gene
in Pseudomonas syringae BR2 [6]. The various ORFs
within this region include sequences similar to b-lactam
synthase, clavaminic acid synthase and enzymes involved
in amino acid synthesis. Additionally, novel ORFs were
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identified in a portion of the biosynthetic region that is
known to be associated with a toxin hypersensitivity phe-
notype [6].
Phaseolotoxin is produced mainly by P. syringae pv.
phaseolicola and pv. actinidae. The molecular structure
of phaseolotoxin includes a sulphodiaminophosphinyl
moiety linked to a tripeptide of ornithine, alanine and
homoarginine [2]. Phaseolotoxin inhibits ornithine car-
bamoyltransferase (OCT, EC 2.1.3.3) [7]. The phaseolo-
toxin homoarginine and ornithine residues are
synthesised by a transamidation reaction that requires
arginine and lysine [8,9].
Aguilera et al. [10] have reported a biosynthetic clus-
ter, pht, which is composed of 23 genes flanked by
insertion sequences and transposases, that is involved in
the biosynthesis of phaseolotoxin. Mutations of 11 of
the genes within the cluster led to a Tox- phenotype,
and the mutation of three additional genes resulted in
low levels of toxin production. Preliminary results also
indicated that the product of phtL may be involved in
the regulation of phaseolotoxin biosynthesis [10].
Pseudomonas syringae pv. syringae (Pss) is a pathogenic
bacterium that can cause canker, blossom blights and
leaf spots in more than 200 different plant species, many
of which are of economic importance [11]. Strains of this
pathovar can cause bacterial apical necrosis on mango
trees, limiting mango production in the Mediterranean
area [12]. More than 86% of the Pss strains isolated from
mango tissues produce mangotoxin, an antimetabolite
toxin that inhibits ornithine N-acetyl-transferase (OAT),
a key enzyme in the biosynthesis of arginine [13]. Mango-
toxin also acts as a virulence factor that increases the
necrotic symptoms of Pss strains during the infection of
plant tissues [14]. In a previous study, a DNA fragment
from Pss, UMAF0158, was cloned into pCG2-6 and
sequenced (DQ532441), revealing a cluster of 4 ORFs
that included the mgoA gene. Our group identified mgoA
as the first P. syringae pv. syringae gene known to be
directly involved in mangotoxin production [15]. This
gene encodes a putative nonribosomal peptide synthetase
(NRPS), and its inactivation by insertional mutagenesis
abolishes mangotoxin production and drastically reduces
virulence [14,15]. The genetic organisation of the three
remaining genes and their roles in the production of
mangotoxin remain unknown. The goal of our current
study is to determine the organisation of the four ORFs
in this cluster (Figure 1) and their relative importance in
the production of mangotoxin.
Results
The gene cluster containing mgoA may constitute an
operon composed of four ORFs. Our current study pro-
vides insight into the organisation of the operon and the
involvement of the genes in the production of
mangotoxin.
The construction and characterisation of insertion
mutants derived from Pseudomonas syringae pv. syringae
UMAF0158
Each ORF that was cloned into plasmid pCG2-6 (Figure 1)
was subjected to insertional inactivation mutagenesis in
the P. syringae pv. syringae UMAF0158 chromosome by
integration of the appropriately cloned PCR products. The
ORFs were 92%-98% identical to the homologous genes in
P. syringae pv. syringae strain B728a (accession no.
CP000075, Table 1). The deduced ORF0 and ORF1 pro-
tein products are homologous to proteins of the HAD
hydrolase family and aldo-keto oxidoreductases, respec-
tively. The mutation of these ORFs by insertional inactiva-
tion did not affect mangotoxin production. ORF2
Figure 1 Organisation of the DNA cloned into pCG2-6 and the locations of the insertional and miniTn5 mutants used in this study.
pCG2-6 contains an 11,103-bp insert of chromosomal DNA derived from Pseudomonas syringae pv. syringae UMAF0158 (GenBank accession
number DQ532441). The site of insertion or miniTn5 within the UMAF0158-3gH1 and UMAF0158-6gF6 mutants (▼) [15] as well as the design of
the insertional mutants (↑) generated in the current study are indicated. The predicted sites of the putative promoters (►) and transcriptional
terminators (○) are indicated. The putative mgo operon involved in mangotoxin production by UMAF0158 is illustrated by grey arrows. Each
gene studied in this study was given a specific name. The ORFs upstream of the mgo operon are illustrated by white arrows, and the 5S and
23S ribosomal RNAs are indicated by black arrows.
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is located just upstream of the putative mgo operon
(Figure 1) and contains a putative ribosomal binding site
(RBS) at nucleotide -6 (AAGAAGT). This gene is 97%
identical to Psyr_5008 from P. syringae pv. syringae B728a
(Table 1), PSPTO_5454 from P. syringae pv. tomato
DC3000 and PSPPH_5087 from P. syringae pv. phaseoli-
cola 1448A. The protein products of the genes from each
of these bacteria were annotated in the database as mem-
bers of the GntR family of transcriptional regulators [16].
When ORF2 was disrupted, the corresponding mutant
UMAF0158::ORF2 still produced mangotoxin (Tables 1
and 2).
The four genes downstream of ORF2 exhibit a high
degree of identity to four consecutive P. syringae pv. syr-
ingae B728a genes (Psyr_5009 to Psyr_5012) (Table 1).
The mgoB gene, which contains a putative RBS at
nucleotide -8 (AGGA), is 96% similar to Psyr_5009,
which encodes a conserved hypothetical protein. The
mgoB mutant UMAF0158::mgoB produced mangotoxin
(Table 1), although the level of mangotoxin was
decreased slightly (Table 2). A search of the Pfam data-
base revealed a similarity to DUF3050, a protein of
unknown function, between amino acids 15 and 244
with an e-value of 3.1e-97. Searches in the InterProScan
(EMBL-EBI) database revealed that the theoretical
MgoB protein product is similar to the haem oxygenase-
like, multi-helical superfamily between amino acids 128
and 245 (e-value of 1.3e-8).
The inactivation of the mgoC, mgoA and mgoD genes
yielded mutants (UMAF0158::mgoC, UMAF0158::mgoA
and UMAF0158::mgoD) that were completely unable to
produce mangotoxin (Tables 1 and 2). The mgoC gene,
which contains a putative RBS at -7 (AAGGA), exhibits
95% similarity to the Psyr_5010 gene of P. syringae pv. syr-
ingae B728a, a conserved hypothetical protein (Table 1).
Homology searches for the MgoC protein product in the
Pfam database revealed a significant match with the p-
aminobenzoate N-oxygenase AurF from Streptomyces
thioluteus. The alignment was between amino acids 2 and
295 with an e-value of 7.2e-88. The disruption of mgoA by
insertion (UMAF0158::mgoA) or miniTn5 (UMAF0158-
6gF6) mutation resulted in the complete inactivation of a
putative nonribosomal peptide synthetase (NRPS). The
inactivation of mgoA has previously been shown to result
in defects in mangotoxin production and considerably
reduced virulence [15]. However, a putative RBS for mgoA
could not be located using the consensus sequences pub-
lished to date. Finally, insertional mutagenesis of the
mgoD gene, which contains a putative RBS at -6 (ATG-
GAG), resulted in the inactivation of a conserved hypothe-
tical protein that is 94% identical to Psy_5012. A
conserved-domain analysis of the hypothetical amino acid
sequence of MgoD revealed sequence similarity to Polyke-
tide_cyc2, a polyketide cyclase/dehydrase and lipid trans-
porter domain, from amino acids 20 to 158. The e-values
were 1e-17 (Specialized BLAST-NCBI) and 1.6e-23
(Pfam).
The genetic organisation of the mgo operon and
complementation of insertional mutants
To define the mgo operon and determine its genetic
organisation and co-transcription, reverse-transcription
PCR (RT-PCR) experiments were performed (Figure 2).
The total DNA and RNA from wild-type UMAF0158
grown in PMS minimal medium at 22°C were used, and
the RT-PCR primers were designed to anneal between
Table 1 Characterization of disrupted genes surrounding the mgo operon in derivates miniTn5 and insertional
mutants from the wild type Pseudomonas syringae pv.syringae UMAF0158 mangotoxin producer
Bacterial strains ORF disrupted Mangotoxin productiona Putative homology of disrupted gene Comparison ncl-nclb with Pss B728a
% of identity gene name
miniTn5 mutantsc
UMAF0158-3νH1 mgoC - Conserved hypothetical protein 95 Psyr_5010
UMAF0158-6νF6 mgoA - Nonribosomal peptide synthetase 93 Psyr_5011
Insertional mutants
UMAF0158::ORF0 ORF0 + HAD hydrolase 92 Psyr_5006
UMAF0158::ORF1 ORF1 + Aldo-keto oxidoreductase 98 Psyr_5007
UMAF0158::ORF2 ORF2 + Transcriptional regulator GntR family 97 Psyr_5008
UMAF0158::mgoB mgoB (+) Haem-oxigenase-likee 96 Psyr_5009
UMAF0158::mgoC mgoC - p-aminobenzoate N-oxygenase AurFe 95 Psyr_5010
UMAF0158::mgoA mgoA - Nonribosomal peptide synthetase 93 Psyr_5011
UMAF0158::mgoD mgoD - Poliketide_cyc2d 94 Psyr_5012
a) Presence of inhibition halo around the bacterial growth point in E. coli growth inhibition test. -: absence of inhibition halo, +: presence of inhibition halo, (+):
slight mangotoxin production (smaller and opaque halo)
b) ncl-ncl is used as abbreviation of nucleotide-nucleotide
c) miniTn5 mutants defective in mangotoxin production obtained in a previous work [15]
d) Putative function by family domains searches
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the ORFs. The total DNA was used as an amplification
control, and the cDNA derived from the mRNA was
used to detect the transcripts of genes belonging to the
putative mgo operon. To confirm the co-transcription of
mgoB, mgoC, mgoA and mgoD, we amplified the con-
necting areas between the sequential ORFs of the puta-
tive mgo operon (Figure 2A). Sequences within ORF2
and mgoB were also amplified to determine their mRNA
transcripts (Figure 2A, B). Our results indicated that
ORF2 and the upstream region and mgoB and the
downstream region were amplified. However, there was
no amplification of the inter-genetic region upstream of
mgoB. These results suggest that the transcriptional unit
is mgoB, mgoC, mgoA and mgoD (Figure 2B). The lack
of amplification between ORF2 and mgoB supports the
presence of a putative promoter in this DNA sequence.
Additional RT-PCR experiments showed that only the
disrupted mgoB gene was not amplified in UMAF0158::
mgoB while the transcripts of the disrupted mgoC gene as
well as that of the downstream genes were absent in
UMAF0158::mgoC (Figure 2C). A hybridisation analysis
of the transcript of the mgo operon with the total mRNA
from wild-type UMAF0158 and the insertional mutants
UMAF0158::mgoB, and UMAF0158::mgoC showed that
the transcript was present in the wild-type strain and
reduced in the mgoB mutant strain (Figure 2D).
To confirm the role of these genes in mangotoxin pro-
duction and to analyse the specific phenotype of each
mutation, we performed a complementation analysis using
plasmids containing all of the genes that were situated
downstream of the mutations (Table 3). The mgo genes
were cloned downstream of the PLAC promoter. Plasmid
pLac36, which contains the structural genes of the operon
(mgoB, mgoC, mgoA and mgoD), and a plasmid containing
the genomic clone pCG2-6 were both able to restore man-
gotoxin production in all of the constructed mutants
(Tables 3 and 2). These results demonstrate that the com-
plemented plasmids were functional and rule out the pos-
sibility that secondary mutations influence mangotoxin
production. Plasmid pLac56, which contains only mgoA
and mgoD, was able to complement the phenotypes of the
miniTn5 mutant UMAF0158-6gF6 and the insertional
mutants UMAF0158::mgoA and UMAF0158::mgoD. Plas-
mid pLac6, however, was only able to complement
UMAF0158::mgoD (Table 3). These complementation
experiments show that the insertional mutants
UMAF0158::mgoC, UMAF0158::mgoA and UMAF0158::
mgoD were unable to produce mangotoxin even when the
downstream genes were restored on a plasmid. The inser-
tional mutation of the mgoC, mgoA and mgoD genes
resulted in a loss of mangotoxin activity, which did not
occur when mgoB was mutated (Tables 1 and 2). There-
fore, we cannot eliminate the possibility that a polar effect
of the insertional mutations affected the phenotypes of the
mutants and downstream genes transcription. Apparently
the insertional mutation in mgoB did not show polar effect
Table 2 Specific inhibition using dilutions of cell-free culture filtrates from Pseudomonas syringae pv.syringae
UMAF0158 and its derived miniTn5 and insertion mutants grown in liquid minimal medium (PMS).
Bacterial strains Mangotoxin production Dilutions of cultures filtratesa
1:1 1:2 1:4 1:8 + ornithine
Wild type
UMAF0158 + 21.7 ± 0.4 18.2 ± 0.4 13.7 ± 0.4 9.5 ± 0.5 < 7
miniTn5 mutants
UMAF0158-3νH1 - < 7 < 7 < 7 < 7 < 7
UMAF0158-6νF6 - < 7 < 7 < 7 < 7 < 7
pCG2-6 complementation
UMAF2-6-3H1 + 19.0 ± 1.0 15.5 ± 0.5 13.5 ± 0.5 9.5 ± 0.5 < 7
UMAF2-6A + 19.0 ± 0.7 16.2 ± 0.4 12.7 ± 1.3 10.5 ± 0.5 < 7
Insertion mutants
UMAF0158::ORF1 + 20.2 ± 1.3 17.0 ± 0.7 14.7 ± 0.8 11.0 ± 0.8 < 7
UMAF0158::ORF2 + 19.7 ± 1.5 16.2 ± 0.8 12.2 ± 1.1 < 7 < 7
UMAF0158::mgoB + 17.7 ± 0.8 14.2 ± 0.8 12.0 ± 0.8 < 7 < 7
UMAF0158::mgoC - < 7 < 7 < 7 < 7 < 7
UMAF0158::mgoA - < 7 < 7 < 7 < 7 < 7
UMAF0158::mgoD - < 7 < 7 < 7 < 7 < 7
pLac complementation
UMAF0158-6νF6 containing pLac56 + 19.2 ± 0.4 15.7 ± 0.8 12.7 ± 1.2 < 7 < 7
UMAF0158-6νF6 containing pLac6 - < 7 < 7 < 7 < 7 < 7
The inhibition analysis was performed by Escherichia coli growth inhibition test
a) Toxic activity is expressed as diameter of inhibition zone (in mm). Average and standard deviation values were obtained from three replicate of three
independent experiments
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Figure 2 Characterisation of the mgo operon: A) diagram of the location of the amplified region obtained during the RT-PCR experiments.
The molecular size and gel lanes are indicated. Lanes 2 and 5 have two molecular sizes: lane 2 shows 306 bp, and line 5 shows 360 bp in
section B; lane 2 shows 401 bp and lane 5 shows 568 bp in section C. The putative mgo operon involved in mangotoxin production by
Pseudomonas syringae pv. syringae UMAF0158 is illustrated by grey boxes, and the upstream ORF is indicated by a white box. Each gene studied
in this study was given a specific name. B) The PCR products obtained from the RT-PCR experiments that used as templates genomic DNA and
mRNA derived from wild-type UMAF0158 after 48 h of incubation at 22°C on liquid PMS minimal medium. C) The PCR products obtained from
the RT-PCR experiments using mRNA from the insertional mutants UMAF0158::mgoB and UMAF0158::mgoC. HyperLadder IV (Bioline) were
subjected to agarose electrophoresis. D) The Northern blot analysis of the total mRNA obtained from wild-type UMAF0158 and the insertional
mutants using a fraction of the mgoC gene as a probe. Lane L, ssRNA ladder; lane 1, UMAF0158; lane 2, UMAF0158::mgoB and lane 3,
UMAF0158::mgoC.
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on mgo genes located downstream (mgoC, mgoA and
mgoD), in contrast with the insertional mutation in mgoC,
which produce a polar effect on mgo downstream genes
transcription (Figure 2, Table 3).
Mangotoxin production in mutants derived from
Pseudomonas syringae pv. syringae UMAF0158
To further support our results, we determined the
amount of mangotoxin production in the insertional
and miniTn5 mutants relative to wild-type UMAF0158
(Table 2). The production of the syringomycin complex
by the insertional mutants confirmed that only mango-
toxin production was affected (data not shown). The
results obtained from the quantitative mangotoxin ana-
lysis indicated that the two miniTn5 mutants that were
complemented with pCG2-6, UMAF2-6A and UMAF2-
6-3H1, and the insertion mutant UMAF0158::ORF1
were able to produce mangotoxin at the same level as
wild-type UMAF0158.
Upon complementation with pLac56 (mgoA and
mgoD), mangotoxin production was restored in the
mutants UMAF0158::ORF2 and UMAF0158::mgoB and
the miniTn5 mutant UMAF0158-6gF6; however, the
production was slightly lower and could be detected
only until a 1:4 dilution (Table 2).
Promoter and terminator localisation in the mgo operon
Promoter expression and terminator localisation experi-
ments were performed to characterise the structure of
the operon.
The promoter prediction software BPROM (SoftBerry
Inc.) was used to identify possible promoters in the puta-
tive mgo operon. The best candidates were found in the
nucleotide sequence (814 bp) of the non-coding region
located upstream of the mgoB gene. Two possible
promoters were predicted and designated as Pmgo. The
first predicted promoter was located at position 134 from
5’-end with a linear discriminant function (LDF) of 0.59, a
-10 box, CGTTTTTAT, at position 119 (score: 37) and a
-35 box, TCGCCA, at position 95 (score: 24). The second
predicted promoter was located at position 549 from the
5’-end of the sequence, with an LDF of 4.38, a -10 box,
TGATAAATT, at position 534 (score: 55) and a -35 box,
TTAAAA, at position 513 (score: 37) (Figure 3C). The
scores of the first predicted promoter were lower than
those of the second promoter. According to the in silica
prediction, the 814 bp sequence containing both putative
promoters was cloned into pMP220, and its activity was
measured with a b-galactosidase assay (b-Gal) [17,18]. The
Pmgo studies were performed in Pseudomonas fluorescens
Pf-5, which contains no genomic sequences that are
homologous to the mgo operon, and P. syringae pv. syrin-
gae B728a, which contains genomic sequences that are
homologous to the mgo operon but cannot produce man-
gotoxin. We also used the insertional mutant UMAF0158::
ORF2, which contains a disruption in the putative tran-
scriptional regulator gene, and wild-type UMAF0158. Pmgo
activity was measured in three different culture media (LB,
KB and PMS) and at two growth temperatures (28°C and
22°C). In the minimal medium PMS, the Pmgo promoter
was active in the wild-type strain at both temperatures
and in the insertional mutant at 22°C (Figure 4). The b-
Gal assays of the strains grown in rich LB and KB media
did not indicate activity in any of the strains at either tem-
perature (data not shown).
Once the presence of promoter activity in the analysed
sequence was confirmed, the 5’RACE method was used
to determine the transcript start point of the mgo operon
(Figure 3A, B). With this method, we could determine
which of the two putative promoters of the mgo operon
Table 3 Analysis of mangotoxin production using miniTn5 and insertional mutants obtained from Pseudomonas
syringae pv.syringae UMAF0158, before and after transformation with plasmids containing total or partial mgo operon
involved in mangotoxin production
Mangotoxin production in strains containing complementing plasmidsa
Strain ORF mutated None pCG2-6 pLac36 pLac56 pLac6
UMAF0158 nab + na na na na
UMAF0158::mgoB mgoB + + + + +
UMAF0158-3νH1 mgoC - + + - -
UMAF0158::mgoC mgoC - + + - -
UMAF0158-6νF6 mgoA - + + + -
UMAF0158::mgoA mgoA - + + + -
UMAF0158::mgoD mgoD - + + + +
a) +: presence of inhibition halo; -: absence of inhibition halo
b) na, not applicable
pCG2-6: genomic clone of UMAF0158. GenBank access DQ532441 (Table 4)
pLac36: mgoB, mgoC, mgoA and mgoD cloned in pBBR1MCS-5 (Table 4)
pLac56: mgoA and mgoD cloned in pBBR1MCS-5 (Table 4)
pLac6: mgoD cloned in pBBR1MCS-5 (Table 4)
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Figure 3 Localisation and analysis of the promoter in the mgo operon. A) The design of the 5’ RACE experiment, including the upstream
and downstream sequences of the mgoB gene. B) The results obtained from the 5’ RACE experiment. Lane 1, amplification from the primer
GSP1; lane 2, amplification from the primer GSP2; lane 3, amplification from the primer GSP3; lane L, loading buffer and HyperLadder I (Bioline),
with the different sizes indicated. C) The 3’-end of ORF2, with the stop codon in bold type, and the 5’-end of mgoB, with the start codon also in
bold type, are indicated. The nucleotide sequence (814 bp) located between these two ORFs was analysed. The two putative promoters found
in this sequence by the in silico analysis are indicated by the locations of the respective -10 and -35 boxes (in red); moreover, the sequence of
the alternative -35 and -10 boxes, which are more closely related to Pseudomonas promoters, are marked in blue. The start of the transcript is
marked as nucleotide +1 (with black point under the nucleotide). The putative ribosomal binding site (RBS) of mgoB is also indicated.
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was the functional promoter and also analyse the pre-
sence of an additional promoter between mgoB and
mgoC, which was suggested by the results of the polarity
and mangotoxin production experiments. The start point
of the transcript (nucleotide +1) was located 18 nucleo-
tides after the predicted -10 box of the second putative
promoter (Figure 3C). Therefore, the second predicted
promoter appears to be the functional promoter for the
mgo operon. At this point using the known nucleotide
sequence and the 5’RACE results, alternative -35 and -10
boxes were located in correct positions from nucleotide
+1. The sequences of these alternative -35 and -10 boxes
are more typical of Pseudomonas sigma70-dependent
promoter sequences [19,20] than the predicted boxes by
BPROM software, which are similar to Escherichia coli
sequences (Figure 3C). Additionally, the results do not
Figure 4 The b-galactosidase (b-Gal) expression of Pseudomonas syringae pv. syringae wild-type UMAF0158, the UMAF0158::ORF2
insertional mutant, Pseudomonas syringae pv. syringae B728a and Pseudomonas fluorescens Pf5 was detected on PMS minimal medium
(without manipulation (□), transformed with empty promoter-probe vector pMP220 (Grey Column) and transformed with pMPmgo,
which contains the putative promoter Pmgo (■)). The cultures were tested at 28°C and 22°C. The results are indicative of three experiments
performed in triplicate. The data were analysed by an analysis of variance (ANOVA) using SPSS 8.0 software for Windows (SPSS Inc., Chicago, IL,
USA). The columns labelled with an asterisk are significantly different (P < 0.01) according to the least significant difference (LSD) test.
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support the presence of an alternative promoter at the
end of mgoB, which could explain the previous results.
The location of the transcriptional terminator was then
determined. A 118-bp sequence was located in the region
downstream of the mgo operon (Figure 5A) and was com-
pared with the equivalent DNA segment in Pss B728a by
Blast (NCBI). A putative terminator (CCC CTC ATC
GCG TAA GCG ATG AGG GG), which was 100% identi-
cal to the equivalent terminator in Pss B728a, was identi-
fied at position 79 from the mgoD stop codon. This
terminator sequence was then analysed by FoldRNA soft-
ware (SoftBerry Inc.), a program used to predict RNA sec-
ondary structure through energy minimisation, to
calculate the free energy released during palindrome struc-
ture formation. A value of -24.4 kcal/mol was found in
84% of the helices. The entire sequence of 118 bp was also
analysed by FindTerm software (SoftBerry Inc.) to locate
putative Rho-independent bacterial terminators. Two
putative terminators (T1 and T2) were found, the first
(T1) of which contained more apparent poly-U tracts typi-
cal of Rho-independent terminators (Figure 5B, C). T1
was located at position 20-57 (-12.5 kcal/mol and 35% in
helices), and T2 was located at position 75-108 (-24.9
kcal/mol and 40% in helices), which includes the sequence
homologous to the B728a terminator. Both terminator
sequences had negative free energy values, indicating that
their folding would be favoured and spontaneous. Finally,
to determine which putative terminator acted as the func-
tional terminator, RT-PCR experiments were performed
by amplifying the 3’-end of the transcript with primers
designed to anneal before, in the middle of and after of the
putative terminators (Figure 5D). The amplification test of
the mgo transcript revealed that the T1 sequence but not
the T2 sequence was included in the mgo transcript, indi-
cating that T1 is the functional terminator of the mgo
operon.
The hypothetical function of the mgo operon
Our study of the mgo locus demonstrates that the mgo
operon is involved in the biosynthesis or regulation of
mangotoxin. Recent studies of the pvf genes, which share
high homology with the mgo operon, have indicated a
possible regulatory function for those genes [21]. Given
these findings, it should be possible to isolate a signalling
molecule that is required for virulence gene expression
and use it to restore the virulence of an mgoA mutant
(defective in the nonribosomal peptide synthetase [15])
by adding this molecule to the growth medium. Growing
the UMAF0158 mutant, which possesses a deletion of
mgoA (UMAF0158ΔmgoA) and is defective in mango-
toxin production, in media supplemented with an extract
from wild-type UMAF0158 restored mangotoxin produc-
tion. An extract from the mgoA mutant did not restore
toxin production. Strains that were defective in other
regulatory genes were also used. Extracts from wild-type
Pss UMAF0158 and the reference strain Pss B728a were
used to complement UMAF0158-2bB7, which contains a
miniTn5 disruption of the gacA gene, and UMAF0158-
3aE10, which contains a miniTn5 disruption of the gacS
gene (Table 4). Mangotoxin production was restored in
the defective mutants when an extract from UMAF0158
was added. By contrast, an extract from Pss B728a only
restored mangotoxin production in the gacS mutant
(Table 4). These results suggest a possible regulatory role
for the mgo operon.
Discussion
The focus of the present study was to characterise the
transcriptional organisation that is directly involved in
mangotoxin production. We had previously identified the
mgo operon (Mangotoxin-Generating Operon) [15]. We
determined which genes are involved in mangotoxin pro-
duction by disrupting each chromosomal gene that was
previously identified in pCG2-6 by mutagenesis. The dis-
ruption of ORF0 and ORF1 did not affect mangotoxin
production. These two genes may belong to another inde-
pendent gene cluster located close to the mgo operon that
is not involved in mangotoxin production. ORF2 tran-
scription was independent of the mgo operon, and ORF2
is homologous to the GntR family of transcriptional regu-
lators. This family of regulatory proteins consists of the N-
terminal HTH region of GntR-like bacterial transcription
factors. An effector-binding/oligomerisation domain is
usually located at the C-terminus [22]. In the deposited
genomes of other P. syringae pathovars, the genes in this
family are often located close to gene clusters that are
homologous to the mgo operon. The relationship between
ORF2 and the regulation of the mgo operon remains
unclear. In the present study, we observed promoter Pmgo
expression in the ORF2 mutant (UMAF0158::ORF2) when
it was grown in minimal medium at 22°C but not at 28°C,
in agreement with the production of mangotoxin by the
ORF2 insertional mutant. These data suggest that ORF2 is
not involved in mangotoxin production but provide no
direct information on the possible influence of ORF2 on
the mgo operon with respect to variations in temperature.
Our results demonstrate that the DNA sequence down-
stream of ORF2 constitutes an operon. Ma et al. [23] first
established the correlation between the presence of a
Shine-Dalgarno sequence, also known as a ribosomal
binding site (RBS), and translational initiation, the expres-
sion levels of the predicted genes and operon structure
[23]. We found putative RBSs in almost all of the genes in
the putative mgo operon. Only the mgoA gene, in which
the start codon overlaps with the stop codon of mgoC,
does contain a potential RBS sequence. mgoC and mgoA
may share the same RBS, and post-translational changes
may separate the two proteins; this situation could explain
Arrebola et al. BMC Microbiology 2012, 12:10
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Figure 5 Study of the terminators located at the end of the mgo operon. A) The organisation of the mgo operon, showing the genes
belonging to the operon as grey boxes, the ORF outside the operon as a white box and the rRNA as black arrows; the promoter (►) and
transcriptional terminators (○) are indicated as T1 and T2. B) The terminal region of the mgo operon, the 3’-end of the mgoD gene (with the
stop codon in bold type) and the 5’-end of the 5S rRNA are indicated. Between these two segments is the nucleotide sequence in which the
two putative terminators were identified by the bioinformatic analysis (SoftBerry Inc.), which are indicated as terminator 1 (T1) and terminator 2
(T2). C) The secondary structure of the two putative Rho-independent terminators within the mgo operon (terminator 1 (T1) and terminator 2
(T2)), as predicted by FindTerm software (SoftBerry Inc.). D) A diagram of the experimental design for locating the functional mgo operon
terminator. The amplicon sizes and primer directions are indicated. Agarose electrophoresis of the RT-PCR experiments. HyperLadder IV (Bioline)
was used as the loading buffer.
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the absence of a putative RBS for the mgoA gene. The
mutagenesis and bioinformatics analysis of each gene in
the mgo operon provided insight into their relationship to
mangotoxin production. The disruption of mgoB did not
abrogate mangotoxin production; however, the production
decreased noticeably compared with the wild-type strain.
Protein domain searches indicated that mgoB is similar to
haem oxygenase. This enzyme is a member of a superfam-
ily represented by a multi-helical structural domain con-
sisting of two structural repeats that is found in both
eukaryotic and prokaryotic haem oxygenases and in pro-
teins that enhance the expression of extracellular enzymes
[24]. The disruption mutants of the next three genes,
mgoC, mgoA and mgoD, were unable to produce mango-
toxin, indicating that these genes are essential for mango-
toxin production. A similar conclusion was reached by
Aguilera et al. [10], who obtained Tox- phenotypes when
11 different genes in the pht cluster, a region involved in
phaseolotoxin production, were mutated by insertion,
indicating that all of the genes located within this region
encode proteins that are required at different stages of
phaseolotoxin production, including synthesis, transport
and regulation [10].
The sequence analysis of mgoC prompted us to search
the superfamily protein domains, revealing a similarity to
the N-oxygenase domain. This domain was identified in
the protein PrnD, which is derived from the pyrrolnitrin
biosynthesis gene cluster of Pseudomonas fluorescens.
MgoC is also similar to AurF from Streptomyces thio-
luteus, which produces the starter unit p-nitrobenzoic acid
(PNBA) for the polyketide synthase of the aureothin bio-
synthesis pathway [25]. The gene mgoA, which is homolo-
gous to non-ribosomal peptide synthetases, is the largest
gene in the mgo operon, and its disruption produces a
mutant that is defective in mangotoxin production. Its
structure, participation in mangotoxin production and
influence on the virulence of the wild-type bacterium has
been discussed previously [15]. The final gene studied was
mgoD; a domain localisation analysis indicated that mgoD
could be a Polyketide_cyc2 belonging to the star-related
lipid-transfer (START) domain superfamily. The START
superfamily includes bacterial polyketide cyclase/aroma-
tases and two families of previously uncharacterised
proteins that are present only in plants and the cyanobac-
terium Prochlorococcus [26].
After analysing the elements that composed the putative
mgo operon, we evaluated whether the four genes were
transcribed together in a single transcript. RT-PCR experi-
ments using the wild-type RNA showed that the four
genes were connected in the single transcript (Figure 2).
Moreover, the transcript size was analysed by hybridisa-
tion, which confirmed the presence of a single transcript
with a sufficient size (about 6 kb) to contain the genes
mgoBCAD; however, the exact size of the transcript could
not be determined.
Following the identification of the mgo operon, the pro-
moter and transcription terminator were identified and
studied. The in silico analysis of the sequence identified
two putative promoters. Promoter activity was detected
only in a minimal medium, the same culture medium
that is traditionally used for antimetabolite toxin assays
[2,13]. Promoter activity occurred in the wild-type strain
at both temperatures and in the ORF2 insertion mutant
at 22°C only. The other Pseudomonas spp. experimental
strains, which do not produce mangotoxin, did not exhi-
bit any b-Gal activity. The promoter activity in the wild-
type strain was more intense at 28°C than 22°C. When
the promoter activity was assayed at 22°C, the activity of
the mutant UMAF0158::ORF2 was statistically compar-
able with that of the wild-type strain. These results sug-
gest a possible influence of ORF2 on the mgo operon
during its regulation in response to temperature varia-
tions. The promoter inactivity in the other two strains of
Pseudomonas spp. may be due to the absence of genes
homologous to the mgo operon in P. fluorescens Pf-5, but
this explanation is not applicable to Pss B728a. The
sequence in B728a that is homologous to the mgo operon
is composed of genes that are orthologous to the mgo
genes; theoretically, the promoter activity should have
been similar to that of the wild-type strain, but it was
not. This result suggests that there are additional genes
that are necessary for mangotoxin production that are
not present in B728a. In support of this explanation,
additional genes involved in mangotoxin production have
been identified in UMAF0158 and cloned into a different
vector than pCG2-6 [15]. The initial sequence analysis
did not show any identity with the genome of B728a, and
thus these additional genes may influence mgo promoter
activity.
Finally, the functional promoter of the mgo operon was
established by locating the start of the mgo transcript
(Figure 4), which is located 18 nucleotides after the puta-
tive -10 box of the second promoter analysed in silico.
Table 4 Extract complementation of defective mutants in
mangotoxin production using extract obtained from
Pseudomonas syringae pv.syringae wild-type UMAF0158
and references train B728a
Controls Extracts
Complemented strains Standard methanol UMAF0158 B728a
P. syringae pv. syringae
UMAF0158 + + nd nd
B728a - - nd nd
Defective mutants
UMAF0158ΔmgoA - - + -
UMAF0158-2bB7 (gacA) - - + -
UMAF0158-3aE10 (gacS) - - + +
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Thus, the first putative promoter was eliminated as a
functional promoter of the mgo operon. Once the +1 site
was established, it was possible to locate additional -35
and -10 boxes, which were typical of sigma70 dependent
promoters of Pseudomonas spp [19,20] and were more
closely related than the predicted -35 and -10 boxes by
BPROM software developed for Escherichia coli, which
are less accurate in the search for promoters of Pseudo-
monas spp. These results allowed us to determine the
functional promoter of the mgo operon. The mgo operon
terminator was found in a similar manner. The in silico
analysis of the sequence identified two possible termina-
tor sequences between the 3’-end of mgoD and the 5’-end
of the 5S rRNA, both of which exhibited secondary struc-
tures typical of transcription terminators. We considered
that the ribosomal transcript terminator is also likely pre-
sent in the analysed sequence. RT-PCR was used to clar-
ify which was the operon terminator, establishing T1 as
the functional terminator of the mgo operon. This is a
typical terminator with a stable hairpin having many GC
pairs followed by a string of T’s. So, it seems that the T1
terminator is a bifunctional terminator, serving this DNA
region to terminate transcription of mgo operon in the
sense strand and of the ribosomal operon in the antisense
strand (Figure 5).
The results described above are sufficient to suggest that
mgoBCAD is a transcriptional unit and therefore propose
that mgo is an operon. If this argument is correct, muta-
tions in each mgo gene should lead to the absence of a
transcript for the downstream genes. A polar effect was
demonstrated for UMAF0158::mgoC but not UMAF0158::
mgoB. The mutation in mgoB did not prevent the tran-
scription of the downstream genes, although the hybridisa-
tion experiments revealed that the transcription appeared
to be less efficient. This reduction in transcription corre-
sponds to the reduced production of mangotoxin by
UMAF0158::mgoB relative to the wild-type strain. There-
fore, the results obtained with wild-type UMAF0158 and
the insertional mutants of mgoC, mgoA and mgoD support
the hypothesis that the mgo genes form an operon in con-
trast, the results with the mutant UMAF0158::mgoB do
not. We also evaluated the possible existence of an alter-
native promoter after the mgoB gene, which would explain
the production of mangotoxin by the mutant UMAF0158::
mgoB. However, during 5’RACE experiment (Figure 3)
only a single transcription start site was located, eliminat-
ing the possibility of another promoter downstream of
mgoB. Therefore there must be something different
between the mutant and wild-type strain, which is prob-
ably the plasmid integration. In reviewing the process by
which the mgo mutants were obtained, we observed that
UMAF0158::mgoB was not easy to obtain. The size of
mgoB is 777 bp, and the cloned sequence in pCR2.1 was
360 bp of mgoB. The integration of pCR::mgoB into mgoB
occurred by single-crossover homologous recombination
as it was confirmed. During this process, the plasmid
could be integrated into mgoB sequence maintaining an
important part of the gene. In this circumstances mgoB or
sufficient fragment of it, and the remarkably other three
genes of the mgo operon, could be under the influence of
a promoter located in plasmid polylinker, lacZ promoter,
allowing a reduced transcript expression (Figure 2) and
mangotoxin production (Tables 1 and 2). To determine
the insert position, a PCR was performed in which the for-
ward primer annealed to the lacZ gene (M13F primer)
and the reverse primer annealed to the 5’-end of the mgoC
gene, with wild-type UMAF0158 used as the negative con-
trol. The amplicon obtained from the mutant
UMAF0158::mgoB had a size of 1000 bp, confirming that
the plasmid pCR::mgoB was integrated and the lacZ pro-
moter is close to mgoB fragment (Additional file 1: Figure
S1).
Because the chemical structure of mangotoxin is
unknown [13], it is difficult to establish a hypothesis con-
cerning the role of the mgo genes in mangotoxin biosynth-
esis or to determine whether they are related to the
regulation of mangotoxin production. Recent studies in P.
entomophila have focussed on the pvf gene cluster, which
is homologous to the mgo operon, and suggest that the
gene cluster serves as a regulator of certain virulence fac-
tors in pathogenic strains of Pseudomonas spp. The pvf
gene cluster may be a new regulatory system that is speci-
fic to certain Pseudomonas species [21]. In the present
study, extract complementation restored mangotoxin pro-
duction in the UMAF0158ΔmgoA mutant only when the
culture medium was supplemented with an extract from
wild-type UMAF0158. Polar effects of the deleted mgoA
on mgoD expression were excluded because the construc-
tion of the deletion mutant preserved the reading phase of
protein translation. Mangotoxin production was restored
in the miniTn5 mutants, which contain disrupted regula-
tory genes, when their cultures were complemented with a
wild-type extract. These results are in agreement with the
results obtained by Vallet-Gely et al. [21], in which pvf
and gac mutants were complemented by a wild-type
extract. These results allow us to propose a putative regu-
latory role for the mgo operon in secondary metabolite
production by P. syringae pv. syringae, in accordance with
Vallet-Gely et al. [21].
To fully characterise the functions of the mgo operon,
more data concerning the chemical structure of mango-
toxin and a characterisation of the other genetic traits that
regulate mangotoxin biosynthesis by P. syringae pv. syrin-
gae UMAF0158 are required.
Conclusions
In the present study, the organisation of the mgo operon
in P. syringae pv. syringae UMAF0158 was characterised.
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The mgo operon is composed of four genes, mgoB,
mgoC, mgoA and mgoD. Additionally, this operon pos-
sesses one active promoter and a terminator. The last
three genes are essential for mangotoxin production, as
insertional mutation of these genes results in a loss of
mangotoxin production. This operon is only active in
minimal medium, in agreement with the standard pro-
cess for mangotoxin production. Moreover, experiments
performed to determine the functional role of the mgo
operon demonstrated a putative regulatory function in
the production of mangotoxin.
Methods
Bacterial strains and plasmids used in this study
The strains of Escherichia coli, Pseudomonas fluorescens
Pf-5 and Pseudomonas syringae pv. syringae as well as
the vectors and plasmids used in this study are listed in
Table 5. E. coli was grown in Luria-Bertani medium
(LB) at 37°C for 24 h. The Pseudomonas strains were
grown routinely in King’s medium B (KB) at 28°C for
48 h. Derivative mutants of P. syringae pv. syringae
UMAF0158 (Table 5) were grown and maintained in KB
supplemented with the appropriate antibiotics (ampicil-
lin, 50 μg/ml; streptomycin, 50 μg/ml; kanamycin,
50 μg/ml; and gentamicin, 20 μg/ml).
Detection of P. syringae toxin production
Syringomycin complex production by strains of P. syringae
strains was detected using growth inhibition tests per-
formed on potato dextrose agar (PDA) against Geotrichum
candidum [32] and nutrient agar against Rhodotorula
pilimanae [33].
Mangotoxin production was assayed using the indica-
tor technique, which has been described previously and
involves growth inhibition of Escherichia coli on Pseudo-
monas Minimal Medium (PMS [34]). Briefly, a double
layer of the indicator microorganism was made with
E. coli CECT831. After solidification, the P. syringae
wild-type strain and its derivatives mutants were stabbed,
and the plates were incubated at 22°C for 24 h, followed
by an additional 24 h at 37°C. To determine the identity
of the biochemical step that is putatively targeted by
mangotoxin, the same plate bioassay was performed in
separate plates with the addition of 100 μl of a 6 mM
solution of ornithine or N-acetyl-ornithine. To assess the
production of mangotoxin in liquid cultures, we used a
cell-free filtrate dilution as previously described [13].
Insertional inactivation mutagenesis
Insertional inactivation mutagenesis of P. syringae pv.
syringae UMAF0158 was used to suppress the production
of mangotoxin by inserting disruption vectors into the
different ORFs of the mgo operon by single-crossover
homologous recombination. To construct the integrative
plasmids (Table 4), DNA fragments of the different ORFs
within the gene cluster were obtained by PCR using pri-
mers specific to the sequence of the genomic clone
pCG2-6 (accession number DQ532441) [15]. PCR, clon-
ing and plasmid purification were carried out following
standard procedures. The plasmids were transformed
into the wild-type strain UMAF0158 by standard electro-
poration. The mangotoxin-deficient phenotype of the
mutants was evaluated by the mangotoxin production
assay described previously. Additionally, the mutants
were analysed by PCR and Southern blot analyses using
the antibiotic resistance cassette or partial target gene
sequences as probes to confirm gene disruption and
select single-copy transformants.
Complementation experiments
To prevent potential polar effects from the mutations
introduced into the mgo operon, a series of plasmids con-
taining the mutated ORF in addition to each of the
downstream ORFs located within the operon was con-
structed. To ensure expression, these constructs were
fused to the PLAC promoter, which is constitutively acti-
vated in P. syringae. A fragment containing mgoB, mgoC,
mgoA and mgoD (7808 bp) was amplified by PCR from
UMAF0158 using the primers ORF3F (5’- CTG CAC
AGC CGA CAC TTT TA -3’) and ORF6R (5’- TCC
GAG GAT CCT GTT GTG GTG CAG CAT CAG TC
-3’). A fragment containing mgoA and mgoD (4107 bp)
was amplified from P. syringae pv. syringae UMAF0158
using the primers ORF5F (5’- CCG CCG GAT CCC
ACT GGT GGC TAA CAT CGT G -3’) and ORF6R;
both primers contained an artificial BamHI site at the 5’
end to facilitate cloning. The amplifications were per-
formed with a high-fidelity Taq polymerase (Expand
High Fidelity PCR System, Roche, Basel, Switzerland),
and the PCR products were cloned into the vector
pGEM-T (Invitrogen, California, USA). The cloned
amplicons were removed from the vector by digestion
with BamHI and individually cloned into the BamHI site
located within pBBR1MCS-5 [29]. The amplicons were
cloned in the direction of transcription downstream from
the PLAC promoter, resulting in plasmids pLac36 (mgoB,
mgoC, mgoA and mgoD) and pLac56 (mgoA and mgoD),
which contained the 7.8-kb and the 4.1-kb amplicons,
respectively. To obtain mgoD alone, pLac56 was digested
with SalI, and the 0.8-kb fragment containing mgoD was
recovered and cloned into pBBR1MCS-5, resulting in
pLac6. The complementing plasmids were introduced
into P. syringae by standard electroporation.
Preparation of RNA for RT-PCR and northern blot
experiments
Pure cultures of the wild-type strain of P. syringae pv.
syringae UMAF0158 were grown for 48 h at 28°C in
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KMB agar to prepare a bacterial suspension in PMS
minimal medium that possessed an optical density of
1.0 at 600 nm (approximately 109 cfu/ml). One millilitre
of this suspension was used to inoculate 50 ml of PMS
minimal medium. The culture was incubated at 22°C for
48 h with orbital shaking. RNA was isolated from the
bacterial culture with a commercial NucleoSpin RNA
Plant kit (Macherey-Nagel GmbH & Co. KG, Germany).
The RNA concentration was determined using a Nano-
drop ND-1000 (NanoDrop Technologies Wilmington,
Table 5 Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristicsa Reference or
source
Escherichia coli
DH5a recA lacZΔM15 [27]
CECT831 Indicator strain of mangotoxin production CECTb
Pseudomonas
fluorescens
Pf-5 Complete genome sequenced and free access. [28]
Pseudomonas syringae pv. syringae
B728a Complete genome sequenced and free access [16]
UMAF0158 Wild type isolated from mango, mangotoxin producer, Nfr [12]
UMAF0158-2bB7
UMAF0158-3aE10
miniTn5 mutants of UMAF0158 in gacA and gacS respectively, defective in mangotoxin, Kmr, Nfr [15]
UMAF0158-3νH1
UMAF0158-6νF6
miniTn5 mutants of UMAF0158, defective in mangotoxin production, Kmr, Nfr [15]
UMAF2-6-3H1
UMAF2-6A
miniTn5 mutants from UMAF0158 and complemented with plasmid pCG2-6, production of
mangotoxin restored, Kmr, Ampr, Nfr
This study
[15]
UMAF0158::ORF0c ORF0 mutant of UMAF0158, ORF0::pCR-ORF0, Kmr, Nfr This study
UMAF0158::ORF1 ORF1 mutant of UMAF0158, ORF1::pCR::ORF1, Kmr, Nfr This study
UMAF0158::ORF2 ORF2 mutant of UMAF0158, ORF2::pCR::ORF2, Kmr, Nfr This study
UMAF0158::mgoB mgoB (ORF3) mutant of UMAF0158, mgoB::pCR::mgoB; Kmr, Nfr This study
UMAF0158::mgoC mgoC (ORF4) mutant of UMAF0158, mgoC::pCR::mgoC; Kmr, Nfr This study
UMAF0158::mgoA mgoA (ORF5) mutant of UMAF0158, mgoA::pCR::mgoA; Kmr, Nfr This study
UMAF0158::mgoD mgoD (ORF6) mutant of UMAF0158, mgoD::pCR::mgoD; Kmr, Nfr This study
UMAF0158ΔmgoA mgoA (ORF5) mutant of UMAF0158 by deletion, Nfr This study
Plasmids
pGEM-T Cloning vector, Ampr Invitrogen,
California, USA
pCR2.1 Cloning vector lacZ, Kmr, Ampr, Invitrogen,
California, USA
pBBR1MCS-5 Cloning vector, Gmr [29]
pMP220 Promoter-probe vector containing a promoterless lacZ gene [30]
pCR::ORF0 integrative plasmid pCR2.1 carrying ORF0 This study
pCR::ORF1 integrative plasmid pCR2.1 carrying ORF1 This study
pCR::ORF2 integrative plasmid pCR2.1 carrying ORF2 This study
pCR::mgoB integrative plasmid pCR2.1 carrying mgoB This study
pCR::mgoC integrative plasmid pCR2.1 carrying mgoC This study
pCR::mgoA integrative plasmid pCR2.1 carrying mgoA This study
pCR::mgoD integrative plasmid pCR2.1 carrying mgoD This study
pCG2-6 genomic clone of UMAF0158 GenBank-DQ532441 [15]
pLac36 From mgoB to mgoD cloned in pBBR1MCS-5 This study
pLac56 mgoA and mgoD cloned in pBBR1MCS-5 This study
pLac6 mgoD cloned in pBBR1MCS-5 This study
pMPmgo pMP220 vector containing the putative promoters of mgo operon This study
pEMG integrative plasmid for deletion mutagenesis, Kmr. [31]
pSW-2 plasmid carrying I-SceI gene for deletion mutagenesis, Gmr. [31]
a) Ampr: ampicillin resistance; Gmr: gentamycin resistance; Kmr: kanamycin resistance; Nfr: Nitrofurantoin resistance. b) CECT: Spanish Type Culture Collection. c)
ORF0 was named in this way because it was cloned as an uncompleted ORF
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DE) and was optimised up to 50 ng/μl for RT-PCR
assays and 1 μg/μl for Northern blotting. The integrity
of the RNA sample was assessed by agarose gel electro-
phoresis. RT-PCR was performed using 100 ng of RNA
at a final volume of 50 μl using the Titan OneTube RT-
PCR system, according to the manufacturer’s instruc-
tions (Roche Diagnostics). The primers were designed
by using sequences located between each gene (Addi-
tional file 2: Table S1). A 40-cycle amplification pro-
gramme (94°C for 30 s, 58°C for 1 min, and 68°C for 1
min) was performed followed by a final extension cycle
at 68°C for 7 min. Positive control reactions that con-
tained DNA isolated from each corresponding bacterial
strain were included in all assays.
Northern blotting was performed using a denaturing
agarose gel (0.7%) and formaldehyde (2.2 M). The sam-
ples were prepared with 20 μg of total RNA in MOPS
running buffer with 2.2. M formaldehyde and 50% for-
mamide and denatured at 65°C for 10 min. The agarose
gel was run for 90 min at 60 V. The RNA was trans-
ferred to a nylon membrane by capillary diffusion using
10× saline-sodium citrate buffer (SSC) and was immobi-
lised by UV cross-linking. The hybridisation was per-
formed with radioactively labelled probes (dCTP32).
Characterisation of the mgo operon promoter
We used pMP220 [30] as the promoter-probe vector to
measure transcriptional activity by b-galactosidase (b-
Gal) expression. The amplicon (1008 bp), which
included the putative promoter region upstream of
mgoB, was cloned into the multicloning site using the
EcoRI and PstI restriction sites, which were not present
in the cloned sequence. The resulting plasmid,
pMPmgo, was transformed into multiple bacterial spe-
cies (Table 5), and b-Gal assays were performed [17,18].
The protocol followed the assay described by J.H. Miller
[18], except for the addition of an extra step. In our
assay, the cells were pelleted and then resuspended in
assay buffer to eliminate any error in the detection of b-
galactosidase enzyme activity due to the effects of differ-
ent carbon sources present in the growth medium.
Additionally, 5’-RACE (Rapid Amplification of cDNA
Ends) experiments were performed to locate the +1
nucleotide in the mgo operon transcript and determine
which putative promoter is active during mgo operon
transcription. The commercial SMART™ RACE cDNA
Amplification Kit (Conthech Laboratory, Inc.) was used.
Moreover, mRNA from UMAF0158 was obtained by a
commercial NucleoSpin RNA Plant kit (Macherey-Nagel
GmbH & Co. KG), as described above.
Extract complementation
Extracts from wild-type UMAF0158 and the mutant
UMAF0158ΔmgoA were used in the complementation
experiments. UMAF0158ΔmgoA, which lacks the mgoA
gene, was created by deletion mutagenesis as described by
Martinez-García and de Lorenzo [31], taking special care to
maintain the reading phase downstream of the mgoD gene.
Extractions from the culture supernatant were performed
as described by Vallet-Gely et al. [21]. Briefly, 200 ml of
bacterial culture in PMS minimal medium was pelleted by
centrifugation after 7 days of growth. The supernatants
were passed through a 0.2-μm filter (Millipore Corporation,
Bedford, MA); the pH was adjusted to 5.0 with HCl or
NaOH, and the preparation was extracted three times with
dichloromethane. Initially, the preparations were extracted
with 100 ml of solvent, then again with 70 ml of solvent
and finally with 50 ml of solvent. The extracts were pooled,
dried with anhydrous Na2SO4, filtered through Whatman
paper, evaporated to dryness and dissolved in 1 ml of
methanol. To supplement the growth medium with extract,
150 μl of methanolic extract was added to a 15-ml PMS
culture, which was subsequently allowed to grow for 24 h.
The mangotoxin production was analysed as previously
described, and cell-free filtrates of UMAF0158 and
UMAF0158ΔmgoA supplemented with extracts from
UMAF0158 and UMAF0158ΔmgoA were tested. Cell-free
filtrates from P. syringae pv. syringae UMAF0158 and
UMAF0158ΔmgoA grown in PMS supplemented with 150
μl of methanol were used as controls, as were cell-free fil-
trates of UMAF0158 and UMAF0158ΔmgoA that were
grown in PMS under standard conditions.
Bioinformatics
Database searches were performed using the website of
the National Center for Biotechnology Information
(NCBI) (http://www.ncbi.nlm.nih.gov). Homology searches
and the analysis of conserved protein domains were per-
formed using the NCBI Specialized BLAST programme,
the protein tools (InterProScan) of the EMBL European
Bioinformatics Institute (http://www.ebi.ac.uk) and the
Pfam database (http://pfam.sanger.ac.uk). The restriction
maps were constructed and analysed using the JustBio
website (http://www.justbio.com). The primers were
designed using Primer3 online software (http://primer3.
sourceforge.net). The annotation and general manipula-
tion of sequences was performed using Artemis software
(Sanger Institute, Cambridge, U.K.). The plasmid maps
were constructed using the programme Plasmid Map
Enhancer 3.1 (Scientific & Educational Software). The pro-
moter prediction was performed by SoftBerry online soft-
ware http://linux1.softberry.com/berry.phtml.
Additional material
Additional file 1: Figure S1. Analysis of the plasmid integration in
UMAF0158::mgoB. The PCR was performed using the M13F primer
located in the lacZ gene of the pCR2.1 cloning vector and the ORF4204R
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primer located in the 5’-end of mgoC. Lane L: HyperLadder I (Bioline),
lane 2: UMAF0158::mgoB, lane 3: UMAF0158, lane 4: negative control of
the PCR reaction.
Additional file 2: Table S1. The annealing position and the sequence of
the utilized primers in RT-PCR experiments.
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